Pancreatic Cancer Research

ResearcherThomas Jefferson UniversityActive in the last 2 years

Qian Zhang

Matched on ORCID iD 0000-0003-4928-3366; OpenAlex author ID A5100401743. Sources: OpenAlex.

Their work

Papers
8 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 8

  1. Efficacy and Safty analysis of low-energy X ray IORT in the treatment of resectable pancreatic cancer Co-author DOI 10.21203/rs.3.rs-3951098/v1↗
  2. HNF4G stimulates the development of pancreatic cancer by promoting IGF2BP2 transcription. First author DOI 10.1007/s12094-022-03048-7↗
  3. Identification of an autophagy-related gene signature for predicting prognosis and immune activity in pancreatic adenocarcinoma. First author DOI 10.1038/s41598-022-11050-w↗
  4. Silencing of FTX suppresses pancreatic cancer cell proliferation and invasion by upregulating miR-513b-5p. First author DOI 10.1186/s12885-021-07975-6↗
  5. Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma. Co-author DOI 10.3389/fimmu.2021.743938↗
  6. LncRNA HOTTIP Participates in Cisplatin Resistance of Tumor Cells by Regulating miR-137 Expression in Pancreatic Cancer. First author DOI 10.2147/ott.s234924↗
  7. Dormant cancer cells contribute to residual disease in a model of reversible pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-12-2067↗
  8. A vaccinia virus encoding the human sodium iodide symporter facilitates long-term image monitoring of virotherapy and targeted radiotherapy of pancreatic cance… Co-author DOI 10.2967/jnumed.112.105056↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunbo Zhao · 2 shared papers, 2021–2024 · strength 0.45
  2. Jiang Deng · 2 shared papers, 2021–2022 · strength 0.33
  3. Yanyu Zhang · 2 shared papers, 2021–2022 · strength 0.33
  4. Yangyang Zhang · 2 shared papers, 2021–2022 · strength 0.33
  5. Di Sun · 1 shared paper, 2024 · strength 0.26
  6. Chunbo Zhao · 1 shared paper, 2023 · strength 0.24
  7. Xu Liu · 1 shared paper, 2023 · strength 0.24
  8. Zhan Jian · 1 shared paper, 2023 · strength 0.24
  9. Shan Li · 1 shared paper, 2021 · strength 0.19
  10. Feng Yin · 1 shared paper, 2020 · strength 0.15
  11. Zhiqiang Ma · 1 shared paper, 2020 · strength 0.15
  12. John P. Morris · 1 shared paper, 2013 · strength 0.03
  13. Wan-Chi Lin · 1 shared paper, 2013 · strength 0.03
  14. Nirakar Rajbhandari · 1 shared paper, 2013 · strength 0.03
  15. Matthias Hebrok · 1 shared paper, 2013 · strength 0.03
  16. Agnieszka Katarzyna Witkiewicz · 1 shared paper, 2013 · strength 0.03
  17. Michael Anthony Hollingsworth · 1 shared paper, 2013 · strength 0.03
  18. Surinder K. Batra · 1 shared paper, 2013 · strength 0.03
  19. Jonathan Robert Brody · 1 shared paper, 2013 · strength 0.03
  20. Kay‐Uwe Wagner · 1 shared paper, 2013 · strength 0.03
  21. Nanhai G. Chen · 1 shared paper, 2012 · strength 0.03
  22. Dana R Haddad · 1 shared paper, 2012 · strength 0.03
  23. Yuman Fong MD · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.